TY - JOUR
T1 - Radical vaginal trachelectomy vs. radical hysterectomy for small early stage cervical cancer
T2 - A matched case-control study
AU - Beiner, M. E.
AU - Hauspy, J.
AU - Rosen, B.
AU - Murphy, J.
AU - Laframboise, S.
AU - Nofech-Mozes, S.
AU - Ismiil, N.
AU - Rasty, G.
AU - Khalifa, M. A.
AU - Covens, A.
PY - 2008/8
Y1 - 2008/8
N2 - Objective: To determine the efficacy and outcome from radical vaginal trachelectomy (RVT) compared to a matched group of patients undergoing radical hysterectomy for small early stage cervical cancer. Methods: All patient data were entered prospectively. Patients wishing preservation of fertility with cervical cancer, tumor < 2 cm, and not meeting the definition of microinvasive cancer were offered RVT. The outcomes were compared to a matched group of patients who underwent radical hysterectomy for stage IA/IB cervical cancer. Groups were matched 1:1 for age (± 5 years), tumor size (± 1 mm), histology, grade, depth of invasion (± 1 mm), presence of capillary lymphatic space invasion, pelvic lymph node metastasis, and adjuvant radiotherapy. Results: A total of 137 patients underwent RVT between 1994 and 2007. Of them, 90 patients were successfully matched. Median tumor size was microscopic. Moreover, 43% and 49% were squamous and had adeno/adenosquamous histology. Median depth of invasion was 3.1 mm. Capillary lymphatic space invasion was present in 68% of cases. Of the tumors, 60% were grade 1, 29% were grade 2, and 11% were grade 3. After a median follow-up of 51 and 58 months, 5 and 1 recurrences were diagnosed in the RVT and radical hysterectomy groups, respectively. Five-year recurrence-free survival rates were present in 95% and 100% of the groups, respectively (p = 0.17). In addition, 3 and 1 deaths occurred in the RVT and radical hysterectomy groups, resulting in 5-year survival rates of 99% and 100%, respectively (p = 0.55). Conclusions: RVT seems to be the procedure of choice for women with small early stage cervical cancers wishing to preserve fertility.
AB - Objective: To determine the efficacy and outcome from radical vaginal trachelectomy (RVT) compared to a matched group of patients undergoing radical hysterectomy for small early stage cervical cancer. Methods: All patient data were entered prospectively. Patients wishing preservation of fertility with cervical cancer, tumor < 2 cm, and not meeting the definition of microinvasive cancer were offered RVT. The outcomes were compared to a matched group of patients who underwent radical hysterectomy for stage IA/IB cervical cancer. Groups were matched 1:1 for age (± 5 years), tumor size (± 1 mm), histology, grade, depth of invasion (± 1 mm), presence of capillary lymphatic space invasion, pelvic lymph node metastasis, and adjuvant radiotherapy. Results: A total of 137 patients underwent RVT between 1994 and 2007. Of them, 90 patients were successfully matched. Median tumor size was microscopic. Moreover, 43% and 49% were squamous and had adeno/adenosquamous histology. Median depth of invasion was 3.1 mm. Capillary lymphatic space invasion was present in 68% of cases. Of the tumors, 60% were grade 1, 29% were grade 2, and 11% were grade 3. After a median follow-up of 51 and 58 months, 5 and 1 recurrences were diagnosed in the RVT and radical hysterectomy groups, respectively. Five-year recurrence-free survival rates were present in 95% and 100% of the groups, respectively (p = 0.17). In addition, 3 and 1 deaths occurred in the RVT and radical hysterectomy groups, resulting in 5-year survival rates of 99% and 100%, respectively (p = 0.55). Conclusions: RVT seems to be the procedure of choice for women with small early stage cervical cancers wishing to preserve fertility.
KW - Cervical cancer
KW - Fertility preservation
KW - Radical surgery
UR - http://www.scopus.com/inward/record.url?scp=47249152195&partnerID=8YFLogxK
U2 - 10.1016/j.ygyno.2008.04.027
DO - 10.1016/j.ygyno.2008.04.027
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 18539313
AN - SCOPUS:47249152195
SN - 0090-8258
VL - 110
SP - 168
EP - 171
JO - Gynecologic Oncology
JF - Gynecologic Oncology
IS - 2
ER -